Reported 14 days ago
This article highlights three high-yield dividend stocks—AbbVie, Gilead Sciences, and Pfizer—recommended for investors to consider in November. AbbVie showcases consistent dividend growth and solid revenue despite challenges, while Gilead demonstrates resilience with a strong dividend increase and a focus on innovative drugs. Pfizer offers an attractive dividend yield and a promising pipeline of products, including several in late-stage development. These stocks present opportunities for both dividend and growth investors.
Source: YAHOO